Skip to content
Politically.com Search all
Menu

Final rule 2025-00425

Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels

The Department of Health and Human Services ("HHS" or "Department") herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in Federal workplace drug testing programs. The Department has revised the drug testing panels for both urine and oral fluid, and revised required nomenclature for laboratory and Medical Review Officer Reports.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2025-00425
Published
Jan 16, 2025
Effective
Jul 7, 2025
Comments close
Not supplied
Federal Register citation
90 FR 4662

CFR references

  • Title 42, chapter 1